PBYI - PUMA BIOTECHNOLOGY INC Latest Stock News Market Updates - StockTitan

PBYI Stock  USD 2.95  0.17  5.45%   
Under 68% of Puma Biotechnology's investor base is looking to short. The analysis of the overall investor sentiment regarding Puma Biotechnology suggests that many traders are alarmed. Puma Biotechnology's investing sentiment shows overall attitude of investors towards Puma Biotechnology.
  
PBYI - PUMA BIOTECHNOLOGY INC Latest Stock News Market Updates StockTitan

Read at news.google.com
Google News at Macroaxis
  

Puma Biotechnology Investor Sentiment by Other News Outlets

Investor sentiment, mood or attitude towards Puma Biotechnology can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

Puma Biotechnology Fundamental Analysis

We analyze Puma Biotechnology's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Puma Biotechnology using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Puma Biotechnology based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Earnings Per Share

Earnings Per Share Comparative Analysis

Puma Biotechnology is currently under evaluation in earnings per share category among its peers. Earnings per Share (EPS) denotes the portion of a company's earnings that is allocated to each share of common stock. To calculate Earnings per Share investors will need to take a company's net income, subtract any dividends for preferred stock, and divide it by the number of average outstanding shares. EPS is usually presented in two different ways: basic and diluted. Fully diluted Earnings per Share takes into account effects of warrants, options, and convertible securities and is generally viewed by analysts as a more accurate measure.

Puma Biotechnology Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Puma Biotechnology stock to make a market-neutral strategy. Peer analysis of Puma Biotechnology could also be used in its relative valuation, which is a method of valuing Puma Biotechnology by comparing valuation metrics with similar companies.

Peers

Puma Biotechnology Related Equities

HEPAHepion Pharmaceuticals   30.61   
0%
100.0%
CHRSCoherus BioSciences   18.57   
0%
60.0%
ARVNArvinas   8.52   
0%
27.0%
MGNXMacroGenics   4.85   
0%
15.0%
VKTXViking Therapeutics   4.30   
0%
14.0%
LRMRLarimar Therapeutics   4.24   
0%
13.0%
HRTXHeron Therapeuti   3.75   
0%
12.0%
CRNXCrinetics Pharmaceuticals   3.10   
0%
10.0%
MDGLMadrigal Pharmaceuticals   1.88   
0%
6.0%
SRPTSarepta Therapeutics   1.77   
0%
5.0%
PTCTPTC Therapeutics   1.44   
0%
4.0%
RAREUltragenyx   0.85   
0%
2.0%
KURAKura Oncology   0.58   
0%
1.0%
RVMDRevolution Medicines   0.27   
0%
1.0%
TSVT2Seventy Bio   1.69   
5.0%
0%
IOVAIovance Biotherapeutics   1.80   
5.0%
0%

Complementary Tools for Puma Stock analysis

When running Puma Biotechnology's price analysis, check to measure Puma Biotechnology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Puma Biotechnology is operating at the current time. Most of Puma Biotechnology's value examination focuses on studying past and present price action to predict the probability of Puma Biotechnology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Puma Biotechnology's price. Additionally, you may evaluate how the addition of Puma Biotechnology to your portfolios can decrease your overall portfolio volatility.
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios